[Anil Tuladhar]

This is the message I received just now from Nepal pharmacy Council.

Dear All
If your concern is for GatiIfloxacin than I want to inform you that this drug not yet approved for therapeutic use in Nepal.
May be some body is exposed in India. Department of Drug Administration, Drug consultative Council, Ministry of Health and Nepal Pharmcy Council are not convinced for any therapeutic benifit of GatiIfloxacin.
For the registration of this GatiIfloxacin any of the referal hospital's Drug and Therapeutic Comittee (DTC) have to send a proposal with full justification to DDA. Now I it is quite impossible.
So we are at least safe aganist any toxicities of GatiIfloxacin.

But I read the Alert Anti-typhoid drug! It is true. We have to use any of the AntiTyphoid drug with preacuation.

Thank you

Dr. D P Khanal
Member
Nepal Pharmacy Council